Skip to content

Net margin at other companies

Amgen logo
AmgenAMGN
21%+3.6pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
29.6%-2.3pp
Gilead Sciences logo
Gilead SciencesGILD
31%+10.2pp
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-508.5%-254pp
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
-123.9%-28.4pp
Nuvation Bio logo
Nuvation BioNUVB
-102.1%-50.6pp

Other financials

Income statement

See full
Revenue-$29.0K-101%
Gross profit$1.2M-60.2%
Operating income-$132.3M+5.2%
Net income-$125.7M-3.9%
EPS (diluted)-$0.85+3.4%

Balance sheet

See full
Cash & equivalents$283.0M-23.1%
Total debt$95.6M-0.5%
Total equity$812.8M-22.1%
Total assets$1.0B-21.6%

Cash flow

See full
Operating cash flow-$132.4M-69.5%
CapEx$390.0K-76.1%
Free cash flow-$132.8M-66.5%

Valuation

See full
Market cap$1.71B+61.1%
Enterprise value$1.53B+102%
P/S26.2×-24.8×

Profitability

See full
Gross margin96.1%-2.7pp
Operating margin-720.8%-313pp
FCF margin-686.5%-273pp

Returns & leverage

See full
Return on equity-47.7%+3.6pp
Debt / equity0.1×0.0×
Current ratio7.1×+0.3×

Where this comes from

Calculated from Vir Biotechnology, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vir Biotechnology, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vir Biotechnology, Inc.'s net margin?
Vir Biotechnology, Inc. (VIR) reported net margin of -676% in Q1 2026.
How has Vir Biotechnology, Inc.'s net margin changed year-over-year?
Vir Biotechnology, Inc.'s net margin increased by 75.6% year-over-year, from -2,769% to -676%.
What is the long-term trend for Vir Biotechnology, Inc.'s net margin?
Over 4 years (2020 to 2025), Vir Biotechnology, Inc.'s net margin has grown at a 13.1% compound annual growth rate (CAGR), from -391.1% to -638.9%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.